pylori-related mucosal injury: Oral administration preferred capsules or solution, taken on an empty stomach Typical range: 250500 mcg/day in divided doses Cycle length: 46 weeks , may extend to 812 weeks for chronic conditions Some practitioners use SubQ in parallel for systemic anti-inflammatory support Potential Problems and Contraindications BPC-157 has a favorable safety profile in animal studies remarkably, no lethal dose (LD50) has been established in rodents even at extremely high doses
Potent, highly absorbable form of BPC-157 Customizable time-release and dosage for a tailored approach Novel, effective, and trusted by thousands of physicians InfiniWell is the exclusive provider of BPC-157 to Fullscript and Emerson Ecologics
heat and light can cause the molecular structure to break down, rendering the medication less effective
Youssef et al., 2012
Science 281(5373):108111 Basson CT, Huang T, Lin RC, Bachinsky DR, Weremowicz S, Vaglio A, Bruzzone R, Quadrelli R, Lerone M, Romeo G, Silengo M, Pereira A, Krieger J, Mesquita SF, Kamisago M, Morton CC, Pierpont ME, Muller CW, Seidman JG, Seidman CE (1999) Different TBX5 interactions in heart and limb defined by Holt-Oram syndrome mutations
The presence of benzyl alcohol is what distinguishes bacteriostatic water from standard sterile water
